MYC and pancreatic neoplasm: Because U1 Adaptor is a new generation gene silencing technology that may serve as a new therapeutic modality for targeting any oncogene [91], U1 Adaptors were translated to target KRAS and MYC, and the adaptors strongly inhibit pancreatic cancer cell proliferation.